1. Home
  2. AKAM vs ASND Comparison

AKAM vs ASND Comparison

Compare AKAM & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Akamai Technologies Inc.

AKAM

Akamai Technologies Inc.

HOLD

Current Price

$119.38

Market Cap

16.7B

ML Signal

HOLD

Logo Ascendis Pharma A/S

ASND

Ascendis Pharma A/S

HOLD

Current Price

$249.85

Market Cap

15.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKAM
ASND
Founded
1998
2006
Country
United States
Denmark
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.7B
15.2B
IPO Year
1999
2014

Fundamental Metrics

Financial Performance
Metric
AKAM
ASND
Price
$119.38
$249.85
Analyst Decision
Buy
Strong Buy
Analyst Count
15
16
Target Price
$107.87
$281.50
AVG Volume (30 Days)
3.4M
482.6K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.71
N/A
Revenue
$2,502,996,000.00
N/A
Revenue This Year
$8.53
$96.35
Revenue Next Year
$7.09
$44.91
P/E Ratio
$172.21
N/A
Revenue Growth
6.96
N/A
52 Week Low
$69.79
$175.19
52 Week High
$165.45
$282.15

Technical Indicators

Market Signals
Indicator
AKAM
ASND
Relative Strength Index (RSI) 47.55 42.88
Support Level $108.21 $215.18
Resistance Level $131.08 $249.89
Average True Range (ATR) 5.07 7.04
MACD 0.82 -2.15
Stochastic Oscillator 52.68 25.30

Price Performance

Historical Comparison
AKAM
ASND

About AKAM Akamai Technologies Inc.

Akamai operates a content delivery network, in which customers store content on distributed servers to deliver it to their own customers more quickly. Akamai has over 350,000 servers distributed over 4,350 points of presence in more than 700 cities globally. This network supports upward of 20% of global internet traffic, generating massive amounts of data. Using data generated by the delivery network, the firm offers cybersecurity products and cloud computing services, ranging from API security to zero-trust enterprise access, which has surpassed the delivery network in revenue and importance. As of 2026, the primary focus has shifted to offering computing hardware as a service, with an emphasis on serving large language model providers such as Anthropic.

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.

Share on Social Networks: